Ontology | Accession | Term | GO Evidence | Evidence Ontology (ECO) Code | Reference | Comments |
---|---|---|---|---|---|---|
Molecular Function | GO:0004521 | endoribonuclease activity |
Inferred from Sequence Model
Term mapped from: InterPro:PIRSF032582
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
||
Biological Process | GO:0043571 | maintenance of CRISPR repeat elements |
Inferred from Sequence Model
Term mapped from: InterPro:PIRSF032582
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
|
Analysis | Accession | Description | Interpro Accession | Interpro Description | Amino Acid Start | Amino Acid Stop | E-value |
---|---|---|---|---|---|---|---|
PANTHER | PTHR34405 | CRISPR-ASSOCIATED ENDORIBONUCLEASE CAS2 | IPR021127 | CRISPR-associated endonuclease Cas2 | 4 | 89 | 1.3E-15 |
Hamap | MF_01471 | CRISPR-associated endoribonuclease Cas2 [cas2]. | IPR021127 | CRISPR-associated endonuclease Cas2 | 4 | 91 | 15.965462 |
CDD | cd09725 | Cas2_I_II_III | IPR021127 | CRISPR-associated endonuclease Cas2 | 6 | 89 | 3.72542E-35 |
NCBIfam | TIGR01573 | JCVI: CRISPR-associated endonuclease Cas2 | IPR021127 | CRISPR-associated endonuclease Cas2 | 4 | 99 | 5.6E-19 |
Pfam | PF09827 | CRISPR associated protein Cas2 | IPR019199 | Virulence-associated protein D / CRISPR associated protein Cas2 | 4 | 81 | 7.2E-25 |
PIRSF | PIRSF032582 | Cas2 | IPR021127 | CRISPR-associated endonuclease Cas2 | 4 | 99 | 5.1E-39 |
Gene3D | G3DSA:3.30.70.240 | - | - | - | 1 | 99 | 1.1E-35 |
SUPERFAMILY | SSF143430 | TTP0101/SSO1404-like | - | - | 4 | 92 | 2.09E-27 |